Aurobindo Pharma reported INR13.22B in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Cipla INR 8.88B 2.74B Jun/2026
Divis Laboratories Ltd INR 11.29B 3.15B Jun/2026
Dr.Reddys Laboratories INR 3.25B 2.36B Jun/2026
Hindustan Unilever INR 35.94B 2.45B Jun/2026
Sun Pharmaceuticals INR 35.57B 8.05B Jun/2026
UPL INR 6.68B 20.64B Jun/2026